Skip to content

Serratus Anterior Plane Block in Patients Undergoing Mastectomy

Serratus Anterior Plane Block: Sub-Serratus vs Supra-Serratus Plane Block for Pain Control in Patients Undergoing Mastectomy

Status
Completed
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03154658
Enrollment
66
Registered
2017-05-16
Start date
2017-04-01
Completion date
2020-03-01
Last updated
2021-03-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pain, Post-operative

Brief summary

This is a randomized, interventional prospective study. Patients (n=66) undergoing mastectomies with or without tissue expander will be randomized to receive a supra-serratus or sub-serratus regional plane block prior to surgery. The main effect to be measured is total opioid consumption 24 hours after the operation. Secondary endpoints include measuring a change between pre-and post-operative pain scores, patient satisfaction of pain control during first 24 hours after the operation, presence of postoperative nausea and vomiting, duration of sleep on first postoperative night, and block performance time and length of stay, between the two treatment arms.

Detailed description

Subjects will be randomized to one of two groups: the supra-serratus anterior plane block (depositing local anesthetic superficial to the serratus anterior muscle) or the sub-serratus anterior plane block (depositing local anesthetic deep to the serratus anterior muscle). Randomization will be performed using a computer generated randomization program. The results of the randomization will be revealed to the physician performing the block just prior to its performance. The site of the block will be marked and a safety timeout will be performed with the block nurse, regional anesthesiologist, and patient present and participating. Once the above is completed, patients will receive a pre-operative ultrasound-guided single-injection serratus anterior plane block using either the supra-serratus or sub-serratus techniques according to their randomization. The block nurse will record the time when the timeout is performed, the needle insertion time when the block needle enters the skin, and the block complete time when the needle exits the skin. If the block is bilateral, the block nurse will record the time when the timeout is performed, then will record two sets of needle in times and needle out times, one for each side. In the case of a bilateral block, the same method of serratus anterior plane block will be utilized for both sides. After the block, the patient will proceed to surgery. The operating room anesthesia team will be notified that the patient received a serratus anterior plane block. An appropriate multimodal general anesthetic will be employed at the operating room anesthesiologist's discretion. Upon completion of the surgery and emergence from general anesthesia, the patient will be seen by study personnel in the Post Anesthesia Care Unit and pain will be evaluated using a 0-10 Likert scale (0=no pain, 10= worst imaginable pain) about 1 hour post-operatively. Pain will be evaluated again by study personnel using the same scale on post-operative day #1, about 24 hours after initial block placement. If the patient is discharged home prior to the post-operative day #1 assessment, a phone interview will be performed 24 hours following the block to evaluate the post-operative day #1 scores and monitor for adverse events. Additional pain scores will be documented in the electronic medical record by nursing staff per protocol, and will be collected by study personnel. During the intraoperative and post-operative period, the patient will continue to receive an appropriate multimodal analgesic regimen as necessary to adequately control the pain. No pain control method will be withheld from the patient as a result of participating in the study. Patient satisfaction scores will also be used as a measure to evaluate quality of perioperative pain management. These scores will be assessed on post-operative day #1 on a scale of 1 to 5 (Poor=1, Fair=2, Good=3 Very good=4, Excellent=5). During follow-up on post-operative day #1, the patients will also be asked for an estimate on duration and quality of sleep to help assess their general comfort level during their first post-operative night. During the routine post-operative visit, an assessment of post-operative nausea and vomiting will be made by asking the patient directly. Chart review looking for post-operative antiemetic usage will also be evaluated to assess the presence of post-operative nausea and vomiting. The decision as to whether or not to perform a serratus anterior plane block (SAPB) will be made independent from the introduction of the patient to the study. Therefore, the patient's choice to receive a SAPB will not be affected by the introduction of the study or their desire to participate in a clinical investigation. A multimodal intraoperative anesthetic technique will be employed for all patients, and post-operative pain control will be managed by the patient's primary surgical team.

Interventions

DRUGRopivacaine 0.35%

The serratus plane block is used to supplement the pain management of a patient receiving a surgical procedure of the chest wall or breast.

Sponsors

University of Texas Southwestern Medical Center
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Subject)

Intervention model description

Randomized interventional prospective model to investigate effect of block placement in two treatment arms. Opioid consumption in the first 24 hours after the operation will be main outcome variable.

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

1. Adult patients 18 years or older 2. Individuals undergoing either a mastectomy or mastectomy with tissue expander for which the anesthetic plan includes a serratus anterior plane block.

Exclusion criteria

1. Any known sensory deficit of the anterolateral chest wall. 2. Any local disorder of the skin or otherwise where blockade is to be performed which would prevent safe performance of the block 3. Pregnancy 4. American Society of Anesthesiology classification greater than 3 5. Allergy to amide local anesthetic medications 6. Chronic pain conditions 7. Preoperative opioid use greater than 20 oral morphine equivalents per day 8. Any coagulation abnormality which would be a contraindication for block placement 9. Preoperative chronic renal dysfunction requiring renal replacement therapy or a serum creatinine greater than 1.4 mg/dL 10. Body mass index \>50 11. Incarceration 12. Inability to understand study procedures including inability to understand the English language 13. Inability to provide adequate informed consent 14. Refusal to participate in the study

Design outcomes

Primary

MeasureTime frameDescription
Opioid Consumption24 hours post blockMeasures number of milligrams morphine equivalents each subject receives

Secondary

MeasureTime frameDescription
Patient Satisfaction Scale24 hours post blockPain satisfaction with regards to post-operative pain management within the first 24 hours post op on a 1-5 Likert scale of (1 poor, 2 fair, 3 good, 4 very good, 5 excellent).
Number of Participants With Nausea/Vomiting24 hours post blockMeasures the type and frequency of anti-emetics subjects receive
Maximum Post-operative Pain Score24 hours post blockMeasures the change in pain scores on a 0-10 Numeric Rating Scale where 0 is no pain and 10 is the maximum pain.
Sleep Duration Night of Postoperative Day 024 hours post blockMeasures the total duration of sleep in minutes that subjects report sleeping on the night after surgery between postoperative days 0 and 1
Block Performance TimeTime from procedure needle insertion until needle removal, estimate less than 5 minutesMeasures total time for block to take effect
Length of Stay10 DaysMeasures total number of days subject is hospitalized, including day of surgery

Countries

United States

Participant flow

Participants by arm

ArmCount
Sub-serratus Regional Block
A regional block using of ropivacaine 0.35% (30 mL will be used per side in patients weighing over 60 kg and 20 mL will be used in patients weighing less than 60 kg) will be administered to the injection site deep to the serratus anterior muscle. Ropivacaine 0.35%: The serratus plane block is used to supplement the pain management of a patient receiving a surgical procedure of the chest wall or breast.
32
Supra-serratus Regional Block
A regional block using of ropivacaine 0.35% (30 mL will be used per side in patients weighing over 60 kg and 20 mL will be used in patients weighing less than 60 kg) will be administered to the injection site superficial to the serratus anterior muscle. Ropivacaine 0.35%: The serratus plane block is used to supplement the pain management of a patient receiving a surgical procedure of the chest wall or breast.
32
Total64

Baseline characteristics

CharacteristicSub-serratus Regional BlockSupra-serratus Regional BlockTotal
Age, Continuous54.7 years
STANDARD_DEVIATION 14.2
52.0 years
STANDARD_DEVIATION 11
53.3 years
STANDARD_DEVIATION 12.7
Axillary node dissection3 participants2 participants5 participants
BMI27.9 kg/m^2
STANDARD_DEVIATION 6.4
30.2 kg/m^2
STANDARD_DEVIATION 10.5
29.0 kg/m^2
STANDARD_DEVIATION 8.7
Intraoperative length321.6 minutes
STANDARD_DEVIATION 110.1
323.0 minutes
STANDARD_DEVIATION 114.7
322.3 minutes
STANDARD_DEVIATION 111.6
Race and Ethnicity Not Collected0 Participants
Region of Enrollment
United States
32 Participants32 Participants64 Participants
Sex: Female, Male
Female
32 Participants32 Participants64 Participants
Sex: Female, Male
Male
0 Participants0 Participants0 Participants
Tissue expander placement24 participants27 participants51 participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
0 / 320 / 32
other
Total, other adverse events
14 / 3215 / 32
serious
Total, serious adverse events
0 / 320 / 32

Outcome results

Primary

Opioid Consumption

Measures number of milligrams morphine equivalents each subject receives

Time frame: 24 hours post block

ArmMeasureValue (MEDIAN)
Sub-serratus Regional BlockOpioid Consumption113.5 milligrams oral morphine equivalent
Supra-serratus Regional BlockOpioid Consumption147 milligrams oral morphine equivalent
Secondary

Block Performance Time

Measures total time for block to take effect

Time frame: Time from procedure needle insertion until needle removal, estimate less than 5 minutes

ArmMeasureValue (MEDIAN)
Sub-serratus Regional BlockBlock Performance Time8 minutes
Supra-serratus Regional BlockBlock Performance Time7.5 minutes
Secondary

Length of Stay

Measures total number of days subject is hospitalized, including day of surgery

Time frame: 10 Days

ArmMeasureValue (MEDIAN)
Sub-serratus Regional BlockLength of Stay2 days
Supra-serratus Regional BlockLength of Stay2 days
Secondary

Maximum Post-operative Pain Score

Measures the change in pain scores on a 0-10 Numeric Rating Scale where 0 is no pain and 10 is the maximum pain.

Time frame: 24 hours post block

ArmMeasureValue (MEAN)Dispersion
Sub-serratus Regional BlockMaximum Post-operative Pain Score5.2 units on a scaleStandard Deviation 4.4
Supra-serratus Regional BlockMaximum Post-operative Pain Score5.9 units on a scaleStandard Deviation 5.2
Secondary

Number of Participants With Nausea/Vomiting

Measures the type and frequency of anti-emetics subjects receive

Time frame: 24 hours post block

ArmMeasureValue (NUMBER)
Sub-serratus Regional BlockNumber of Participants With Nausea/Vomiting14 participants
Supra-serratus Regional BlockNumber of Participants With Nausea/Vomiting15 participants
Secondary

Patient Satisfaction Scale

Pain satisfaction with regards to post-operative pain management within the first 24 hours post op on a 1-5 Likert scale of (1 poor, 2 fair, 3 good, 4 very good, 5 excellent).

Time frame: 24 hours post block

ArmMeasureValue (MEAN)Dispersion
Sub-serratus Regional BlockPatient Satisfaction Scale3.62 units on a scaleStandard Deviation 1.01
Supra-serratus Regional BlockPatient Satisfaction Scale3.24 units on a scaleStandard Deviation 0.91
Secondary

Sleep Duration Night of Postoperative Day 0

Measures the total duration of sleep in minutes that subjects report sleeping on the night after surgery between postoperative days 0 and 1

Time frame: 24 hours post block

ArmMeasureValue (MEAN)Dispersion
Sub-serratus Regional BlockSleep Duration Night of Postoperative Day 0315 minutesStandard Deviation 114
Supra-serratus Regional BlockSleep Duration Night of Postoperative Day 0276 minutesStandard Deviation 80.4

Source: ClinicalTrials.gov · Data processed: Feb 21, 2026